AIDS News and Research

RSS

Global vaccine sales up 16% in 2009, report says

Global vaccine sales "grew by a healthy 16 percent last year, when sales shot up to $22.1 billion, healthcare market research publisher Kalorama Information reported Friday," according to the Associated Press. Kalorama is also forecasting sales "will rise at a compound annual rate of 9.7 percent during the next five years," (Johnson, 8/14).

17 Aug 2010

Menopause is not the end of women's love life

Menopause doesn't have to signal the end of a woman's love life. In fact, most women can enjoy even better sex after their reproductive years if they follow some healthy advice. Sex is good exercise and slows the aging process, so it's not only permissible but also smart to keep it a central part of one's lifestyle.

16 Aug 2010

Opinions: PEPFAR funding; Aid in Africa; Obama, human rights

Following a recent letter by Sen. Richard Lugar (R-Ind.) to President Barack Obama that "expressed concern about the future of" PEPFAR "as details of the Obama administration's Global Health Initiative emerge," a Courier-Journal editorial looks at how the "U.S. made a commitment to be a major player in the worldwide fight against AIDS" and details how "arguably the most successful program implemented by President Bush" has made huge strides in broadening HIV treatment access and preventing mother-to-child-transmission in the developing world.

16 Aug 2010

FDA approves ellaOne for emergency contraception

HRA Pharma announced today that the US Food and Drug Administration (FDA) granted approval for ella(R) (ulipristal acetate) as a prescription-only emergency contraceptive indicated for use within 120 hours (five days) of unprotected intercourse or a known or suspected contraceptive failure. ella is not intended for routine use as a contraceptive.

16 Aug 2010

Activists, care providers, patients protest against Senator Nelson's silence on AIDS drug program

While Florida continues to add up to 300 people each month to its waiting list for its AIDS Drug Assistance Program, scores of AIDS activists, care providers and patients will gather at a protest and press briefing hosted by AIDS Healthcare Foundation, Friday, August 13th at 12:00 Noon outside the Tampa offices of United States Senator Bill Nelson (D, FL).

13 Aug 2010

Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPs

Bristol-Myers Squibb Company and the ADAP Crisis Task Force today announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs to provide antiretroviral medicines to people living with HIV and AIDS. Building on an agreement signed in March of 2010, today's announcement marks a multi-year enhancement to assist ADAPs in meeting the challenges of increasing patient case loads and strained government funding.

12 Aug 2010

HIV patients want docs to pay attention to other health conditions exacerbated by HIV

HIV/AIDS patients need their doctors to pay more attention to their other health conditions that can be exacerbated by HIV or its treatments, especially now that people are living longer with HIV. That is according to a international study of 2,000 patients that two Chicago-area health providers were instrumental in carrying out.

12 Aug 2010

Early administration of TXA reduces death from bleeding without increase in complications: Study

If recently injured patients with serious bleeding were to receive a cheap, widely available and easily administered drug to help their blood to clot, tens of thousands of lives could be saved every year, according to a paper published on-line today by The Lancet.

12 Aug 2010

University of Maryland receives grant from NCRR to acquire superconducting NMR spectrometer

The University of Maryland, in partnership with the University of Maryland, Baltimore and University of Maryland Baltimore County, has received a $7.9 million federal grant to acquire a superconducting 950 MHz Nuclear Magnetic Resonance (NMR) magnet that will help researchers unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

12 Aug 2010

AHF led sustained advocacy campaign leads to BMS's offer of discounts in AIDS drug pricing

Following ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need, that the last remaining major AIDS drug company, Bristol-Myers Squibb (BMS) today announced an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide.

12 Aug 2010

Africa needs policies, regulations to spur development of innovative mobile phone-based applications

The fast-growing use of cell phones in Africa - where many people lack the basic human necessities - has made headlines worldwide the past few years. The surprising boom has led to widespread speculation that cell phones could potentially transform the impoverished continent.

10 Aug 2010

Al Shabaab demands World Vision to close operations in Somalia

World Vision Somalia received a demand today from Al Shabaab to close operations in Somalia. World Vision guards were disarmed and their keys were taken. Nothing was removed from the offices although Al Shabaab representatives occupied the offices.

10 Aug 2010

AHF launches new ad campaign 'President Obama, The War on AIDS Has Not Been Won'

As part of its ongoing advocacy efforts to spur President Obama and the Administration to do more on AIDS, AHF is rolling out an ad headlined "President Obama, The War on AIDS Has Not Been Won" which compares the amount of U.S. dollars spent fighting the global AIDS epidemic vs. the amount spent on the war in Afghanistan. The ad features a scale with the globe on one side and the words "Global War on AIDS: $6.5 billion in 2010" and a map of Afghanistan on the other side with the words "Afghanistan War: $102 billion in 2010."

10 Aug 2010

Scientists identify compound to inhibit wild-type HIV-1 protease

Drug resistance remains a major problem in combating HIV infection, but a different approach to drug development could be the answer.Current viral inhibitors target the HIV-1 protease function with a competitive mechanism. Writing in the BJ ChemBio Knowledge Environment of the Biochemical Journal, Max Chang and colleagues from the Scripps Research Institute, La Jolla, suggest that pharmaceutical companies look at compounds that use an allosteric non-competitive mechanism of inhibition.

10 Aug 2010

CQ Weekly reports on advocates' response to Obama administration's domestic, global HIV/AIDS efforts

CQ Weekly examines how HIV/AIDS advocates are "[i]Increasingly dissatisfied with [President Barack] Obama's approach, both at home and abroad." According to the article, some advocates say that Obama and congressional Democrats "have failed to show the political will and marshal the necessary resources" to fight HIV/AIDS.

10 Aug 2010

Lancet World Report examines how U.N. Women agency will work to address global health issues

A Lancet World Report article examines how many are looking to the new U.N. agency tasked with advancing women's equality and rights to help improve the health of women in developing countries.

10 Aug 2010

Female Health Company third-quarter net revenues decrease 75% to $1.8 million

The Female Health Company, which manufactures and markets the FC2 Female Condom®, today reported its operating results for the third quarter and first nine months of FY2010.

7 Aug 2010

BMS to join ranks of AIDS drug companies to offer price concessions

Bristol-Myers Squibb will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial AIDS Directors, is expected to be announced any day. BMS has been the target of a sustained advocacy campaign led by AHF over its pricing of its key AIDS drug Reyataz.

7 Aug 2010

Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs

"Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year's worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world," Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.

7 Aug 2010

Clinical trials in Asia, Africa confirm safety, effectiveness of rotavirus vaccine

Two studies published online Thursday in the Lancet show that the rotavirus vaccine is safe and effective at preventing much of the gastrointestinal illness in developing countries, where rotavirus kills more than 400,000 children under age 5 annually, Reuters reports. Based on the findings in Asia and Africa, the studies' authors "urged the governments of developing nations to make the vaccines a priority," the news service writes.

7 Aug 2010

AIDS News and Research

Global vaccine sales up 16% in 2009, report says

Menopause is not the end of women's love life

Opinions: PEPFAR funding; Aid in Africa; Obama, human rights

FDA approves ellaOne for emergency contraception

Activists, care providers, patients protest against Senator Nelson's silence on AIDS drug program

Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPs

HIV patients want docs to pay attention to other health conditions exacerbated by HIV

Early administration of TXA reduces death from bleeding without increase in complications: Study

University of Maryland receives grant from NCRR to acquire superconducting NMR spectrometer

AHF led sustained advocacy campaign leads to BMS's offer of discounts in AIDS drug pricing

Africa needs policies, regulations to spur development of innovative mobile phone-based applications

Al Shabaab demands World Vision to close operations in Somalia

AHF launches new ad campaign 'President Obama, The War on AIDS Has Not Been Won'

Scientists identify compound to inhibit wild-type HIV-1 protease

CQ Weekly reports on advocates' response to Obama administration's domestic, global HIV/AIDS efforts

Lancet World Report examines how U.N. Women agency will work to address global health issues

Female Health Company third-quarter net revenues decrease 75% to $1.8 million

BMS to join ranks of AIDS drug companies to offer price concessions

Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs

Clinical trials in Asia, Africa confirm safety, effectiveness of rotavirus vaccine

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News